Player FM - Internet Radio Done Right
22 subscribers
Checked 2y ago
Lagt til nine år siden
Innhold levert av cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!
Gå frakoblet med Player FM -appen!
The Promise of Immunotherapy in Lung Cancer
Manage episode 120493211 series 98519
Innhold levert av cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Dr. Leena Gandhi of Dana-Farber Cancer Institute sees great potential in immune therapies for lung cancer. In this video, she expresses her hope and excitement for what the future may hold. February 2014.
301 episoder
Manage episode 120493211 series 98519
Innhold levert av cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Dr. Leena Gandhi of Dana-Farber Cancer Institute sees great potential in immune therapies for lung cancer. In this video, she expresses her hope and excitement for what the future may hold. February 2014.
301 episoder
Alle episoder
×G
GRACEcast Lung Cancer Video
1 Should Small Cell Lung Cancer Patients Who Respond to Chemo Receive Consolidation Radiotherapy? 4:36
4:36
Spill senere
Spill senere
Lister
Lik
Likt
4:36Dr. Nasser Hanna outlines the possible benefits of consolidation chest radiation for small cell lung cancer patients who respond well to chemotherapy.
G
GRACEcast Lung Cancer Video
1 Should All Small Cell Lung Cancer Patients Receive Prophylactic Cranial Irradiation? 5:28
5:28
Spill senere
Spill senere
Lister
Lik
Likt
5:28The doctors discuss the circumstances under which small cell lung cancer patients should receive prophylactic cranial irradiation.
G
GRACEcast Lung Cancer Video
1 Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer? 2:27
2:27
Spill senere
Spill senere
Lister
Lik
Likt
2:27Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.
G
GRACEcast Lung Cancer Video
1 Angiogenesis, the Sequel: Does Cyramza (Ramucirumab) Make a Difference for Second Line Treatment? 7:28
7:28
Spill senere
Spill senere
Lister
Lik
Likt
7:28The REVEL trial studied 1,200 non-small cell lung cancer patients to see if the drug Cyramza (ramucirumab) improved overall surival. The doctors had mixed feelings about the results.
G
GRACEcast Lung Cancer Video
1 Zykadia for ALK Positive Lung Cancer: New Drug, New Hope 7:22
7:22
Spill senere
Spill senere
Lister
Lik
Likt
7:22The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases.
G
GRACEcast Lung Cancer Video
1 What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer 3:52
3:52
Spill senere
Spill senere
Lister
Lik
Likt
3:52"Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined how patients with high MET expression did on the drug MetMab (onartuzumab).
G
GRACEcast Lung Cancer Video
1 MET-Amplified Lung Cancer: A New Target for XALKORI? 7:18
7:18
Spill senere
Spill senere
Lister
Lik
Likt
7:18Lung cancer patients with high MET amplification appear to do well on Xalcori (crizotinib), a drug that is approved for ALK positive patients.
G
GRACEcast Lung Cancer Video
1 CO1686 - 3rd Generation Drug for Acquired Resistance in EGFR Lung Cancer 4:10
4:10
Spill senere
Spill senere
Lister
Lik
Likt
4:10Lung cancer patients with the EGFR mutation who had progressed on other drugs did well on a new drug in clinical trial, though one particular side effect concerns some.
G
GRACEcast Lung Cancer Video
1 FGFR and Its Role in Treating Squamous Cell Lung Cancer 2:21
2:21
Spill senere
Spill senere
Lister
Lik
Likt
2:21Fibroblast growth factor receptor (FGFR) mutations may play a role in the growth of squamous cell lung cancer. Dr. Jonathan Riess talks about what they are learning in this area.
G
GRACEcast Lung Cancer Video
1 AZD9291 for Acquired Resistance in EGFR Positive Lung Cancer 11:36
11:36
Spill senere
Spill senere
Lister
Lik
Likt
11:36EGFR positive lung cancer patients who had seen cancer progression responded well to a new drug in an early clinical trial.
G
GRACEcast Lung Cancer Video
1 What Are Heat Shock Protein (HSP) 90 Inhibitors and How May They Help Fight Lung Cancer? 2:17
2:17
Spill senere
Spill senere
Lister
Lik
Likt
2:17"HSP 90 inhibitors are a really cool class of drugs..." states Dr. Melissa Johnson of the Robert H. Lurie Comprehensive Cancer Center as she describes what researchers are learning about these drugs still in early development. February 2014.
G
GRACEcast Lung Cancer Video
1 The Promise of Immunotherapy in Lung Cancer 1:21
1:21
Spill senere
Spill senere
Lister
Lik
Likt
1:21Dr. Leena Gandhi of Dana-Farber Cancer Institute sees great potential in immune therapies for lung cancer. In this video, she expresses her hope and excitement for what the future may hold. February 2014.
G
GRACEcast Lung Cancer Video
1 Does Gilotrif Help EGFR Positive Lung Cancer Patients? 8:16
8:16
Spill senere
Spill senere
Lister
Lik
Likt
8:16An analysis of two large studies of EGFR lung cancer patients tried to determine if Gilotrif helped patients live longer.
G
GRACEcast Lung Cancer Video
Progression-free survival is something that doctors measure to determine how well a patient responds to a particular treatment. But does it translate to increased overall survival?
G
GRACEcast Lung Cancer Video
1 DDR2 Mutations in Squamous Cell Lung Cancer 1:07
1:07
Spill senere
Spill senere
Lister
Lik
Likt
1:07A genetic mutation and a leukemia drug may provide new hope for patients with squamous cell lung cancer patients.
Velkommen til Player FM!
Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.